RTN3 and metabolic dysfunction-associated steatotic liver disease: The results showed that the RNA levels of RTN3 were increased dramatically in the NAFLD patient group, HFD mouse group, and steatosis‐steatohepatitis diet (SSD) mouse group compared to healthy controls (Figure 1A–C).